Synergy Extreme India

अपने चरम सेवा प्रदाता.
CATEGORIES
 
  • Company News
  • Local News
  • Outsourcing News
  • Technology News
  • Uncategorized
  • ARCHIVE
     
  • May 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 201
  •    
    Vetter’s Chicago Facility is Fully Operational

     

    A contract development and the manufacturing organization that specializes in the aseptic filling is the vetter.  The first to use Bosch’s a new MHI 2020 B fully automated vial filler Vetter Chicago facility offers state  of the art technology and the processes to support the preclinical through the Phase II compounds.  The fully automated vial filler at Vetter’s Chicago facility prepared for the capping.  The designed specifically for the early clinical stage, high value biopharmacauticals, Vetters new automated vial filler can run up to 10,000  liquid or 6,000 lyophilized vials per batch.

    The minimum tubing lengths help reduce API loss and increase product yield, the systems use of the restricted access barrier system and its degree of the automation including the both filing and capping.  The unit is capable of the running a range of the fill volumes from the 0.1 to 23 ml providing the ample flexibility.  The intend for the liquid fills a second clean room houses  a flexible semi-automated filler.  The system can fill a variety of packaging materials, syringes, cartridges and vials with a capacity of up to 500 units per batch. Both automated and semi automated units provide a 100 percent in line check weigh system which helps ensure accurate  fill volume critical in a small, early stage fills because of the no sampling is required to verify the fill volumes.

    The facility uses exclusively disposable components in the material preparations, compounding and filtration areas which eliminates the need for the cleaning validation and saves valuable time and cost.  The third cleanroom will expand current operations and provides a filling of the pre sterilized syringes. Their Chicago facility provides a customers with a top of the line clinical manufacturing site located in the heart of the United States this is because Vetter consistently strives to stay the forefront of the innovation. The outsourcing helps to improve the industry.  The strategic to vetters plan for the worldwide growth, the launch of the Chicago operations in highlights dedication to serving the North American market where nearly half of Vetters clients base resides.

    The Chicago site and its processes meet the stringent FDA and EMA quality requirements.  The services include the regulatory counsel and the product lifecycle management.  The experienced project managers steer all the product development projects so that it can stay a quality standards that can be maintained and deliverables that can be met on the time and on the budget.  The Chicago facility provides seamless product transfers to Vetters ,large scale manufacturing facilities in the Europe for the Phase III and the commercial manufacturing.

    REFERENCE:

    http://www.pharmpro.com/news/2011/10/outsourcing-news-Vetters-Chicago-Facility-is-Fully-Operational/

    Leave a Reply

    You must be logged in to post a comment.